Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 436Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Androgel

02 1Androgel

03 2Axiron

04 2Testopel

05 2Tostran/Fortesta

PharmaCompass

01

03

04

05

07

Brand Name : Testopel

Testosterone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Testopel

arrow
2024 ACI Convention
Not Confirmed

Testosterone

Main Therapeutic Indication : Endocrinology

Currency : USD

2022 Revenue in Millions : 39

2021 Revenue in Millions : 44

Growth (%) : -11

blank

08

Brand Name : Testopel

Testosterone

arrow
2024 ACI Convention
Not Confirmed

Brand Name : Testopel

arrow
2024 ACI Convention
Not Confirmed

Testosterone

Main Therapeutic Indication : Endocrinology

Currency : USD

2023 Revenue in Millions : 42

2022 Revenue in Millions : 39

Growth (%) : 10

blank

09

Brand Name : Axiron

Testosterone

arrow
2024 ACI Convention
Not Confirmed

10

Brand Name : Axiron

Testosterone

arrow
2024 ACI Convention
Not Confirmed